DNA Testing Market Research Reveals Strong 9.9% CAGR Outlook Through 2030

The field of DNA testing is rapidly advancing, driven by technological innovations and expanding applications across healthcare and forensic sectors. As this market evolves, it is set to experience substantial growth, fueled by new medical insights and improved diagnostic tools. Here's an in-depth look at the current state, key players, emerging trends, and segmentation within the DNA testing market.

Projected Expansion and Market Size of the DNA Testing Industry
The DNA testing market is poised for robust growth over the coming years, expected to reach a valuation of $32.71 billion by 2030. This reflects a strong compound annual growth rate of 9.9%. Factors contributing to this expansion include the integration of precision medicine, advancements in AI-driven genetic interpretation, widespread population screening initiatives, growth in clinical genomics, and supportive regulations for molecular diagnostics. During the forecast period, important trends will involve the increased use of DNA testing in clinical diagnostics, prenatal and newborn screening, oncology, pharmacogenomics, the adoption of automated testing platforms, and a rising demand for personalized genetic information.

The dna testing market size has grown rapidly in recent years. It will grow from $20.04 billion in 2025 to $22.4 billion in 2026 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to advances in molecular diagnostics, infectious disease testing demand, cancer screening adoption, laboratory automation growth, genetic research funding.

Download a free sample of the dna testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15358&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Companies Shaping the DNA Testing Sector
The DNA testing market features several prominent organizations driving innovation and market presence. Leading companies include F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, dic*kinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies, Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., Ancestry.com LLC, 23andMe Holding Co., Ambry Genetics Corporation, MyHeritage Ltd., Biocartis SA, CENTOGENE N.V., Everlywell Inc., Atlas Biomed Group Limited, and Veritas Genetics.

A notable industry move occurred in January 2023, when QIAGEN N.V., a Netherlands-based biotech firm, acquired Verogen Inc. for $150 million. This acquisition is part of QIAGEN's strategy to reinforce its leadership in human identification and forensic markets by incorporating Verogen's next-generation sequencing technology and services. Verogen, headquartered in the US, specializes in forensic genomics and offers advanced DNA testing tools for forensic analysis and human identification.

View the full dna testing market report:
https://www.thebusinessresearchcompany.com/report/dna-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Trends Driving Advancements in DNA Testing
Companies in the DNA testing space are increasingly focusing on next-generation diagnostic tools, especially precancer detection tests that facilitate early diagnosis and intervention to improve patient outcomes. These tests identify genetic or epigenetic markers, like mutations or methylation patterns, associated with early-stage cancer development before symptoms appear.

As an example, in November 2023, Lucid Diagnostics Inc., a US-based company specializing in esophageal cancer prevention, introduced EsoGuard 2.0. This next-generation esophageal DNA test enhances assay accuracy and reduces costs by employing advanced molecular techniques to increase DNA yield. Using the EsoCheck Cell Collection Device, the test analyzes esophageal cell DNA through bisulfite conversion, PCR amplification, and next-generation sequencing to detect gene-specific methylation changes linked to esophageal precancer and cancer, providing clinicians with a valuable early detection tool.

Comprehensive Segmentation of the DNA Testing Market
The DNA testing market report categorizes the industry into several segments to better understand its scope:

1) Product Type:
- Equipment
- Consumables
- Software and Services

2) Technology:
- Polymerase Chain Reaction (PCR) Based
- In-Situ Hybridization
- Microarray
- Next-Generation Sequencing (NGS) DNA Diagnosis

3) Application:
- Newborn DNA Screening
- Pre-Natal DNA Carrier Screening
- Oncology Diagnostics and Histopathology
- Pre-implantation Diagnosis
- Infectious Disease Diagnostics
- Pharmacogenomics Diagnostic Testing
- Identity Diagnostics and Forensic
- Other Applications

Further subcategories provide detailed breakdowns:
- Equipment includes PCR machines, sequencing instruments, microarray systems, and electrophoresis equipment.
- Consumables cover PCR reagents, sequencing reagents, hybridization reagents, enzymes, and buffers.
- Software and services involve data analysis software, laboratory information management systems (LIMS), bioinformatics services, as well as consulting and technical support.

This structured approach offers a clear picture of the diverse components and technologies fueling the growth and innovation in DNA testing worldwide.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.